64 results
8-K
EX-10.3
PHIO
Phio Pharmaceuticals Corp
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
424B5
PHIO
Phio Pharmaceuticals Corp
1 Jun 23
Prospectus supplement for primary offering
5:00pm
additional amounts on the debt securities in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem … and be discharged from the obligation to pay any additional amounts upon the occurrence of particular events of tax, assessment or governmental charge
424B5
n25bsscegjqqxtcxrf
19 Apr 23
Prospectus supplement for primary offering
5:06pm
424B5
3l2nfczrdb3r2n2e5
17 Feb 21
Prospectus supplement for primary offering
8:55am
8-K
EX-10.2
q01mgbv
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm